Endovision Co.
Latest round
- Series A
Last raised
- Dec 2020
Total raised
- $2.6M
Investors
- 2
About Endovision Co.
, Ltd., Ltd. is dedicated to providing advanced medical solutions, having been established in 2013 in Daegu, South Korea. The company's founder has a history in the medical device sector, though specific details about prior ventures are unavailable.Endovision specializes in the development and manufacturing of innovative medical devices, with a strong focus on biocompatible products such as their flagship KIOMER M3, a patented bio-polymer regenerative material. This product is designed using a proprietary chemical treatment process that enhances the properties of chitosan, resulting in a material that exhibits significant antibacterial, hemostatic, anti-inflammatory, and moisturizing effects. KIOMER M3 is particularly effective at reducing the expression of inflammatory cytokines in wound healing, adsorbing harmful ammonia molecules, and providing a strong hemostatic response due to its positive charge interacting with negatively charged red blood cells and platelets.Endovision generates revenue through the direct sale of its medical products and devices, particularly the KIOMER M3 line, to hospitals and healthcare providers. The company employs a business-to-business (B2B) transaction model, engaging in partnerships and contracts with medical institutions and wholesalers, ensuring that its innovative solutions reach end-users effectively. Given the nature of the medical device industry, transactions typically involve bulk orders, where institutions procure significant quantities of products based on their clinical needs. The pricing structure for these products is aligned with the value delivered, reflecting their advanced technology and efficacy in medical applications., Ltd. The company aims to launch new medical devices tailored to expanding markets, although specific product release dates and targeted geographic regions for expansion have not been disclosed, indicating a strategic focus on growth in the medical device sector.
Who invested in Endovision Co.
2 investors across 1 round
See all investors in Endovision Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 31, 2020
Amount
$2.6M
Investors
Questions about Endovision Co.
Who invested in Endovision Co.?
Endovision Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Endovision Co. raised?
Endovision Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Endovision Co. last raise money?
Endovision Co.'s most recent round on record is a Series A, in Dec 2020.
What does Endovision Co. do?
Endovision Co. is a medical devices & equipment company.
Where is Endovision Co. headquartered?
Endovision Co. is headquartered in Daegu, South Korea.
Which VCs invest in companies like Endovision Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Endovision Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Endovision Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.